touchPODCAST

touchPANEL DISCUSSION for touchIMMUNOLOGY

Listen to key experts as they discuss the pathophysiology of eosinophilic oesophagitis (EoE) and provide their perspectives on the similarities and differences in its clinical presentation in children vs adults, the transition of care from paediatric to adult services, and the current and future treatment options for patients with EoE.

The experts

Dr Nirmala Gonsalves - Northwestern University Feinberg School of Medicine, Chicago, USA

Dr Sharon Hall - Imperial College Healthcare NHS Trust, London, UK

Dr Salvatore Oliva - Sapienza University of Rome, Rome, Italy

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi. This activity is jointly provided by USF Health and touchIME. 

For further information please visit our website: https://touchimmunologyime.org/

touchPANEL DISCUSSION for touchRESPIRATORY 

Listen to key experts as they discuss the pathophysiology of eosinophilic oesophagitis (EoE) and provide their perspectives on the similarities and differences in its clinical presentation in children vs adults, the transition of care from paediatric to adult services, and the current and future treatment options for patients with EoE.

The experts

Dr Nirmala Gonsalves - Northwestern University Feinberg School of Medicine, Chicago, USA

Dr Sharon Hall - Imperial College Healthcare NHS Trust, London, UK

Dr Salvatore Oliva - Sapienza University of Rome, Rome, Italy

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi. This activity is jointly provided by USF Health and touchIME. 

For further information please visit our website: https://touchrespiratoryime.org/

touchPANEL DISCUSSION for touchNEUROLOGY

Listen to a panel of leading multiple sclerosis (MS) experts discuss their perspectives on the benefits of disease-modifying therapies (DMTs) in MS, and current approaches to treatment sequencing. 

The experts

• Prof. Gavin Giovannoni (Chair), Blizard Institute, Queen Mary University of London, UK

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent educational grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchneurology.com/cme/treatment-sequencing-in-ms-the-benefits-of-dmts/ 

touchPANEL DISCUSSION for touchONCOLOGY

Listen to a panel of leading breast cancer specialists discuss their perspectives on risk stratification and future therapies in HR+ HER2- early breast cancer.

The experts

• Dr Carlos Barrios - Hospital São Lucas PUCRS, Porto Alegre, Brazil

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical education grant from Lilly USA, LLC (Lilly). This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/high-risk-hrpositive-her2negative-early-breast-cancer-risk-stratification-and-treatment-strategies/

touchIN CONVERSATION for touchONCOLOGY

Listen to Dr Randy Broun, a community oncologist and haematologist, in conversation with Dr Faith Davies, a multiple myeloma expert. They respond to questions submitted by the HCP audience and provide their expert insights on how real-world evidence can guide the management of elderly and frail patients with multiple myeloma.

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Takeda Pharmaceuticals USA Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: www.touchoncology.com

touchPANEL DISCUSSION for touchONCOLOGY

Listen to three experts discuss the treatment of recurrent/metastatic head and neck squamous cell carcinoma (HNSCC), including the latest clinical trial data and how it informs clinical practice, and how patient priorities can be established and incorporated into the care plan.

The experts

• Prof. Lisa Licitra - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent grant from the healthcare business of Merck KGaA, Darmstadt. This activity is jointly provided by USF Health and touchIME. 

For further information visit our website: https://touchoncology.com/cme/treatment-provision-recurrent-metastatic-hnscc/

touchMDT for touchIMMUNOLOGY

Listen to leading experts engage in a case-based discussion on the management of EoE, covering both current practice and therapeutic options on the horizon.

The multidisciplinary team

• Allergist/immunologist: Prof. Jonathan Spergel, USA

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi. This activity is jointly provided by USF Health and touchIME. 

For further information visit our website: https://touchimmunologyime.org/mdt-improving-outcomes-in-eoe/

touchMDT for touchIMMUNOLOGY

Listen to a multidisciplinary team of experts as they explore the symptoms of EoE and their impact on patients in a case-based discussion of an adult newly presenting with food impaction.

The multidisciplinary team 

• Gastroenterologist: Prof. Arjan Bredenoord, The Netherlands

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi. This activity is jointly provided by USF Health and touchIME. 

For further information visit our website: https://touchimmunologyime.org/mdt-improving-outcomes-in-eoe/

touchMDT for touchIMMUNOLOGY

Listen to leading experts discuss the environmental, genetic and immunological factors that contribute to the development of eosinophilic oesophagitis. 

The multidisciplinary team

• Allergist/immunologist: Prof. Jonathan Spergel, USA

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchimmunologyime.org/mdt-improving-outcomes-in-eoe/

touchMDT for touchRESPIRATORY

Listen to leading experts engage in a case-based discussion on the management of EoE, covering both current practice and therapeutic options on the horizon.

The multidisciplinary team

• Allergist/immunologist: Prof. Jonathan Spergel, USA

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi. This activity is jointly provided by USF Health and touchIME. 

For further information visit our website: https://touchrespiratoryime.org/mdt-improving-outcomes-in-eoe/